Sarepta Therapeutics (SRPT) EBITDA (2010 - 2026)
Sarepta Therapeutics' quarterly EBITDA came in at $358.4 million in Q1 2026, up 219.32% year-on-year from $112.2 million in Q1 2025, and up 187.09% quarter-over-quarter from -$411.6 million in Q4 2025.
Sarepta Therapeutics has reported EBITDA for 17 years, with the latest figure at $358.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 219.32% year-over-year to $358.4 million; the trailing twelve-month figure through Mar 2026 stood at -$36.0 million (up 62.36% YoY), and the FY2025 full-year result was -$699.8 million, down 420.88% from the prior year.
- EBITDA for Q1 2026 stood at $358.4 million, up from -$411.6 million in the prior quarter.
- The five-year high for EBITDA was $358.4 million in Q1 2026, with the low at -$515.5 million in Q1 2023.
- Average EBITDA over 5 years is -$78.6 million, with a median of -$40.5 million recorded in 2023.
- Peak annual rise in EBITDA reached 3115.28% in 2025, while the deepest fall reached 970.43% in 2025.
- Tracing SRPT's EBITDA over 5 years: stood at -$107.7 million in 2022, then surged by 143.83% to $47.2 million in 2023, then soared by 242.46% to $161.7 million in 2024, then sank by 354.56% to -$411.6 million in 2025, then jumped by 187.09% to $358.4 million in 2026.
- The last three EBITDA figures came in at $358.4 million (Q1 2026), -$411.6 million (Q4 2025), and -$179.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 358.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 358.43 Mn |
| Dec 31, 2025 | -411.58 Mn |
| Sep 30, 2025 | -179.68 Mn |
| Jun 30, 2025 | 196.81 Mn |
| Mar 31, 2025 | -300.39 Mn |
| Dec 31, 2024 | 161.68 Mn |
| Sep 30, 2024 | 36.89 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 34.51 Mn |
| Dec 31, 2023 | 47.21 Mn |
| Sep 30, 2023 | -40.52 Mn |
| Jun 30, 2023 | -24.58 Mn |
| Mar 31, 2023 | -515.51 Mn |
| Dec 31, 2022 | -107.70 Mn |
| Sep 30, 2022 | -258.46 Mn |
| Jun 30, 2022 | -233.66 Mn |
| Mar 31, 2022 | -105.31 Mn |
| Dec 31, 2021 | -121.98 Mn |
| Sep 30, 2021 | -48.17 Mn |
| Jun 30, 2021 | -81.40 Mn |
| Mar 31, 2021 | -167.26 Mn |
| Dec 31, 2020 | -189.31 Mn |
| Sep 30, 2020 | -196.51 Mn |
| Jun 30, 2020 | -151.44 Mn |
| Mar 31, 2020 | -16.92 Mn |
| Dec 31, 2019 | -235.73 Mn |
| Sep 30, 2019 | -126.33 Mn |
| Jun 30, 2019 | -276.34 Mn |
| Mar 31, 2019 | -76.53 Mn |
| Dec 31, 2018 | -141.00 Mn |
| Sep 30, 2018 | -76.02 Mn |
| Jun 30, 2018 | -108.99 Mn |
| Mar 31, 2018 | -35.63 Mn |
| Dec 31, 2017 | -24.37 Mn |
| Sep 30, 2017 | -47.71 Mn |
| Jun 30, 2017 | -63.03 Mn |
| Mar 31, 2017 | 84.16 Mn |
| Dec 31, 2016 | -88.57 Mn |
| Sep 30, 2016 | -56.74 Mn |
| Jun 30, 2016 | -62.30 Mn |
| Mar 31, 2016 | -59.66 Mn |
| Dec 31, 2015 | -64.79 Mn |
| Sep 30, 2015 | -51.92 Mn |
| Jun 30, 2015 | -41.85 Mn |
| Mar 31, 2015 | -61.48 Mn |
| Dec 31, 2014 | -44.46 Mn |
| Sep 30, 2014 | -29.25 Mn |
| Jun 30, 2014 | -33.85 Mn |
| Mar 31, 2014 | -28.33 Mn |
| Dec 31, 2013 | -8.82 Mn |
| Sep 30, 2013 | -42.03 Mn |
| Jun 30, 2013 | -19.05 Mn |
| Mar 31, 2013 | -42.08 Mn |
| Dec 31, 2012 | -62.07 Mn |
| Sep 30, 2012 | -49.55 Mn |
| Jun 30, 2012 | 8.04 Mn |
| Mar 31, 2012 | -17.70 Mn |
| Dec 31, 2011 | -1.41 Mn |
| Sep 30, 2011 | -4.02 Mn |
| Jun 30, 2011 | 1.28 Mn |
| Mar 31, 2011 | 1.83 Mn |
| Dec 31, 2010 | -1.74 Mn |
| Sep 30, 2010 | -3.80 Mn |
| Jun 30, 2010 | -7.67 Mn |